BC is home to pioneering co-op employers and researchers who played a key role in developing COVID-19 vaccines and treatments:

• Acuitas Therapeutics continues to develop best-in-class LNP delivery systems, proven to be incredibly effective for mRNA Vaccines and next-generation CRISPR therapies.
• NanoVation Therapeutics is advancing LNP delivery for cardiometabolic and rare diseases.
• Genevant Sciences holds more than 700 LNP patents and maintains global pharmaceutical partnerships.
• Cytiva, formerly Precision NanoSystems, specializes in LNP formulations.
• Evonik Canada offers GMP manufacturing services for RNA therapeutics.

Overall, B.C. is positioning itself as a launchpad for next-generation therapeutics and vaccines, with a focus on scalable, sustainable innovation in life sciences.